Prof. Thomas Powles joins us in Berlin to share his perspectives on the latest bladder cancer data presented at ESMO 2025.
Prof. Powles reviews data from the following studies:
KEYNOTE-905: Perioperative enfortumab vedotin plus pembrolizumab in participants with muscle-invasive bladder cancer who are cisplatin-ineligible: The phase 3 study. Vulsteke C, et al. Abstract LBA2, ESMO 2025
ALBAN: A phase 3, randomised, open-label, international study of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) vs BCG alone in BCG-naïve high-risk, non-muscle-invasive bladder cancer. Roupret M, et al. Abstract LBA107, ESMO 2025
IMvigor011: a phase 3 trial of circulating tumour DNA-guided adjuvant atezolizumab vs placebo in muscle-invasive bladder cancer. Powles T.B, et al. Abstract LBA8, ESMO 2025
How will these data impact clinical practice? Watch to find out!
See more updates from ESMO 2025 on our website: https://cor2ed.com/n-connect/programm...
Looking for similar GU cancer programmes?
Update From ASCO 2025: https://cor2ed.com/n-connect/programm...
Interactive patient case video: Shared decision-making for prostate cancer patients: https://cor2ed.com/gu-connect/program...
Follow GU CONNECT on:
X – https://x.com/guconnectinfo
LinkedIn – / gu-connect
This video was developed by cor2ed.com
Published October 2025
Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.
Поделиться в:
Доступные форматы для скачивания:
Скачать видео mp4
Информация по загрузке:
Скачать аудио mp3
Похожие видео
array(20) {
["oA50ZWPTUG0"]=>
object(stdClass)#5903 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "oA50ZWPTUG0"
["related_video_title"]=>
string(150) "Основные моменты конференции ESMO 2025 по раку мочевыводящих путей: PSMAddition, Capitello-281, P..."
["posted_time"]=>
string(25) "3 недели назад"
["channelName"]=>
NULL
}
["b05LmoD_ySE"]=>
object(stdClass)#5913 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "b05LmoD_ySE"
["related_video_title"]=>
string(117) "Новые достижения в лечении рака предстательной железы в 2025 году"
["posted_time"]=>
string(27) "9 месяцев назад"
["channelName"]=>
NULL
}
["lgNQHKtNtvI"]=>
object(stdClass)#5901 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "lgNQHKtNtvI"
["related_video_title"]=>
string(47) "A Better Treatment than BCG for Bladder Cancer?"
["posted_time"]=>
string(28) "10 месяцев назад"
["channelName"]=>
NULL
}
["W4ZKV5TLcPk"]=>
object(stdClass)#5911 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "W4ZKV5TLcPk"
["related_video_title"]=>
string(25) "Highlights from ESMO 2025"
["posted_time"]=>
string(25) "3 недели назад"
["channelName"]=>
NULL
}
["kVe5IVg9cfs"]=>
object(stdClass)#5895 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "kVe5IVg9cfs"
["related_video_title"]=>
string(51) "Shared decision-making for prostate cancer patients"
["posted_time"]=>
string(23) "1 месяц назад"
["channelName"]=>
NULL
}
["S9FKw6N28Is"]=>
object(stdClass)#5906 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "S9FKw6N28Is"
["related_video_title"]=>
string(48) "Чем грозит прием СТАТИНОВ?"
["posted_time"]=>
string(25) "2 недели назад"
["channelName"]=>
NULL
}
["spYTMygao9Q"]=>
object(stdClass)#5899 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "spYTMygao9Q"
["related_video_title"]=>
string(47) "Episode 32: ESMO 2025 Commentary: Kidney Cancer"
["posted_time"]=>
string(25) "2 недели назад"
["channelName"]=>
NULL
}
["_1w1e4_jQ6o"]=>
object(stdClass)#5910 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "_1w1e4_jQ6o"
["related_video_title"]=>
string(97) "15 способов убить раковые клетки. ЭТО ЛЕЧИТ онкологию."
["posted_time"]=>
string(27) "7 месяцев назад"
["channelName"]=>
NULL
}
["L6sB-uV1wbM"]=>
object(stdClass)#5889 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "L6sB-uV1wbM"
["related_video_title"]=>
string(169) "ЭНЗАРАД: энзалутамид с АДТ и лучевой терапией при раке предстательной железы высокого риска"
["posted_time"]=>
string(25) "3 недели назад"
["channelName"]=>
NULL
}
["pva2B9nblBs"]=>
object(stdClass)#5907 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "pva2B9nblBs"
["related_video_title"]=>
string(99) "I Couldn’t Stop Peeing! Frequent Urination to Bladder Cancer | Bladder Cancer | The Patient Story"
["posted_time"]=>
string(27) "9 месяцев назад"
["channelName"]=>
NULL
}
["apUp2-BkgWQ"]=>
object(stdClass)#5902 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "apUp2-BkgWQ"
["related_video_title"]=>
string(131) "Как лечить рак мочевого пузыря в 2025 году с доктором Жоакимом Бельмунтом"
["posted_time"]=>
string(27) "8 месяцев назад"
["channelName"]=>
NULL
}
["Rhanu0SucIc"]=>
object(stdClass)#5908 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "Rhanu0SucIc"
["related_video_title"]=>
string(152) "Юлия Высоцкая — впервые о состоянии дочери Маши, 140 миллиардах и пополнении в семье"
["posted_time"]=>
string(21) "1 день назад"
["channelName"]=>
NULL
}
["Rt8HQpdyVY0"]=>
object(stdClass)#5896 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "Rt8HQpdyVY0"
["related_video_title"]=>
string(74) "ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA"
["posted_time"]=>
string(25) "4 месяца назад"
["channelName"]=>
NULL
}
["WtAPURcb2L8"]=>
object(stdClass)#5894 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "WtAPURcb2L8"
["related_video_title"]=>
string(171) "⚡️НОВОСТИ | МУЖЧИНА ВЫПАЛ ИЗ ОКНА | ЗАДЕРЖАН МИНИСТР | ЭВАКУАЦИЯ В СТОЛИЦЕ | БЕНЗИН РАЗБАВЛЯЮТ"
["posted_time"]=>
string(24) "15 часов назад"
["channelName"]=>
NULL
}
["E4ElgFzqF9M"]=>
object(stdClass)#5892 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "E4ElgFzqF9M"
["related_video_title"]=>
string(68) "Next-Generation Immunotherapy for NMIBC: QUILT 2.005 and QUILT 3.032"
["posted_time"]=>
string(19) "1 год назад"
["channelName"]=>
NULL
}
["yJZ1kvW9Xn4"]=>
object(stdClass)#5893 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "yJZ1kvW9Xn4"
["related_video_title"]=>
string(132) "Прямой эфир проекта «Мы вам поможем!», посвященный раку молочной железы."
["posted_time"]=>
string(69) "Трансляция закончилась 4 недели назад"
["channelName"]=>
NULL
}
["wBElxUPjLH4"]=>
object(stdClass)#5890 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "wBElxUPjLH4"
["related_video_title"]=>
string(161) "Специальный выпуск ESMO 2025: профессор Тагава представляет результаты исследования PSMAddition"
["posted_time"]=>
string(25) "3 недели назад"
["channelName"]=>
NULL
}
["zFSUxJXxOAg"]=>
object(stdClass)#5891 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "zFSUxJXxOAg"
["related_video_title"]=>
string(100) "Is There a Cure for Myeloma? Leading Myeloma Expert Dr. Sundar Jagannath on Why Cure is Within Reach"
["posted_time"]=>
string(23) "1 месяц назад"
["channelName"]=>
NULL
}
["lhRhJeACRhc"]=>
object(stdClass)#5879 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "lhRhJeACRhc"
["related_video_title"]=>
string(119) "Анализ на ПСА: кому, когда и как сдавать. Что делать с результатом?"
["posted_time"]=>
string(25) "4 недели назад"
["channelName"]=>
NULL
}
["2v9POD652Ts"]=>
object(stdClass)#5880 (5) {
["video_id"]=>
int(9999999)
["related_video_id"]=>
string(11) "2v9POD652Ts"
["related_video_title"]=>
string(0) ""
["posted_time"]=>
string(19) "1 год назад"
["channelName"]=>
NULL
}
}
